170 related articles for article (PubMed ID: 37391754)
1. MRI-based breast cancer radiogenomics using RNA profiling: association with subtypes in a single-center prospective study.
Park AY; Han MR; Seo BK; Ju HY; Son GS; Lee HY; Chang YW; Choi J; Cho KR; Song SE; Woo OH; Park HS
Breast Cancer Res; 2023 Jun; 25(1):79. PubMed ID: 37391754
[TBL] [Abstract][Full Text] [Related]
2. Radiogenomic Analysis of Breast Cancer by Using B-Mode and Vascular US and RNA Sequencing.
Park AY; Han MR; Park KH; Kim JS; Son GS; Lee HY; Chang YW; Park EK; Cha SH; Cho Y; Hong H; Cho KR; Song SE; Woo OH; Lee JH; Cha J; Seo BK
Radiology; 2020 Apr; 295(1):24-34. PubMed ID: 32013793
[TBL] [Abstract][Full Text] [Related]
3. Association between rim enhancement of breast cancer on dynamic contrast-enhanced MRI and patient outcome: impact of subtype.
Schmitz AM; Loo CE; Wesseling J; Pijnappel RM; Gilhuijs KG
Breast Cancer Res Treat; 2014 Dec; 148(3):541-51. PubMed ID: 25376743
[TBL] [Abstract][Full Text] [Related]
4. Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms.
Grimm LJ; Zhang J; Mazurowski MA
J Magn Reson Imaging; 2015 Oct; 42(4):902-7. PubMed ID: 25777181
[TBL] [Abstract][Full Text] [Related]
5. Imaging features of triple-negative breast cancers according to androgen receptor status.
Candelaria RP; Adrada BE; Wei W; Thompson AM; Santiago L; Lane DL; Huang ML; Arribas EM; Rauch GM; Symmans WF; Gilcrease MZ; Huo L; Lim B; Ueno NT; Moulder SL; Yang WT
Eur J Radiol; 2019 May; 114():167-174. PubMed ID: 31005169
[TBL] [Abstract][Full Text] [Related]
6. Novel biomarkers identified in triple-negative breast cancer through RNA-sequencing.
Chen YL; Wang K; Xie F; Zhuo ZL; Liu C; Yang Y; Wang S; Zhao XT
Clin Chim Acta; 2022 Jun; 531():302-308. PubMed ID: 35504321
[TBL] [Abstract][Full Text] [Related]
7. Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.
Kim JJ; Kim JY; Suh HB; Hwangbo L; Lee NK; Kim S; Lee JW; Choo KS; Nam KJ; Kang T; Park H
Eur Radiol; 2022 Feb; 32(2):822-833. PubMed ID: 34345946
[TBL] [Abstract][Full Text] [Related]
8. Radiogenomics analysis reveals the associations of dynamic contrast-enhanced-MRI features with gene expression characteristics, PAM50 subtypes, and prognosis of breast cancer.
Ming W; Zhu Y; Bai Y; Gu W; Li F; Hu Z; Xia T; Dai Z; Yu X; Li H; Gu Y; Yuan S; Zhang R; Li H; Zhu W; Ding J; Sun X; Liu Y; Liu H; Liu X
Front Oncol; 2022; 12():943326. PubMed ID: 35965527
[TBL] [Abstract][Full Text] [Related]
9. MR Imaging Findings in Molecular Subtypes of Breast Cancer According to BIRADS System.
Navarro Vilar L; Alandete Germán SP; Medina García R; Blanc García E; Camarasa Lillo N; Vilar Samper J
Breast J; 2017 Jul; 23(4):421-428. PubMed ID: 28067435
[TBL] [Abstract][Full Text] [Related]
10. Relationships Between MRI Breast Imaging-Reporting and Data System (BI-RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement is Associated with Luminal B Subtype.
Grimm LJ; Zhang J; Baker JA; Soo MS; Johnson KS; Mazurowski MA
Breast J; 2017 Sep; 23(5):579-582. PubMed ID: 28295860
[TBL] [Abstract][Full Text] [Related]
11. Association between MRI Features and Standardized Uptake Value of 18F-FDG PET/CT in Triple-Negative Breast Cancer.
Choi BB; Lee JS; Kim KH
Oncol Res Treat; 2018; 41(11):706-711. PubMed ID: 30321870
[TBL] [Abstract][Full Text] [Related]
12. Quantitative MRI morphology of invasive breast cancer: correlation with immunohistochemical biomarkers and subtypes.
Bae MS; Seo M; Kim KG; Park IA; Moon WK
Acta Radiol; 2015 Mar; 56(3):269-75. PubMed ID: 24558165
[TBL] [Abstract][Full Text] [Related]
13. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
[TBL] [Abstract][Full Text] [Related]
14. MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study.
Holli-Helenius K; Salminen A; Rinta-Kiikka I; Koskivuo I; Brück N; Boström P; Parkkola R
BMC Med Imaging; 2017 Dec; 17(1):69. PubMed ID: 29284425
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis-, proliferation, immune function-, and drug resistance- related genes in ER positive, HER2 positive and triple negative breast cancer.
Kolacinska A; Chalubinska J; Zawlik I; Szymanska B; Borowska-Garganisz E; Nowik M; Fendler W; Kubiak R; Pawlowska Z; Morawiec Z; Szemraj J
Neoplasma; 2012; 59(4):424-32. PubMed ID: 22489698
[TBL] [Abstract][Full Text] [Related]
16. Is there a correlation between 3T multiparametric MRI and molecular subtypes of breast cancer?
Montemezzi S; Camera L; Giri MG; Pozzetto A; Caliò A; Meliadò G; Caumo F; Cavedon C
Eur J Radiol; 2018 Nov; 108():120-127. PubMed ID: 30396643
[TBL] [Abstract][Full Text] [Related]
17. Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling.
Yeh AC; Li H; Zhu Y; Zhang J; Khramtsova G; Drukker K; Edwards A; McGregor S; Yoshimatsu T; Zheng Y; Niu Q; Abe H; Mueller J; Conzen S; Ji Y; Giger ML; Olopade OI
Cancer Imaging; 2019 Jul; 19(1):48. PubMed ID: 31307537
[TBL] [Abstract][Full Text] [Related]
18. Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up.
Yang SX; Polley EC
Breast Cancer Res Treat; 2019 Jun; 175(2):287-295. PubMed ID: 30746635
[TBL] [Abstract][Full Text] [Related]
19. Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations.
Bergeron A; MacGrogan G; Bertaut A; Ladoire S; Arveux P; Desmoulins I; Bonnefoi H; Loustalot C; Auriol S; Beltjens F; Degrolard-Courcet E; Charon-Barra C; Richard C; Boidot R; Arnould L
Mod Pathol; 2021 Jul; 34(7):1282-1296. PubMed ID: 33753865
[TBL] [Abstract][Full Text] [Related]
20. Gene expression comparison between primary estrogen receptor-positive and triple-negative breast cancer with paired axillary lymph node metastasis.
Srour MK; Qu Y; Deng N; Carlson K; Mirocha J; Gao B; Dadmanesh F; Cui X; Giuliano AE
Breast J; 2021 May; 27(5):432-440. PubMed ID: 33464691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
